Tag: Novo Nordisk A/S

Trump plans generic drug tariffs from 2028 with two-year delay testing U.S. onshoring push

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

Fat cat? Weight-loss drugs may be coming for your overweight pet

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

Healthy Returns: Employers aren’t expanding coverage of GLP-1 obesity drugs – many are finding ways around it

Healthy Returns: Walmart, CVS step in to help seniors navigate Medicare coverage of obesity drugs 

Medicare will start covering obesity drugs for the first time. Here’s what patients should know

Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet

Estrogen patches are hard to find, and it may not be resolved any time soon

UPS to invest $48 million in temperature-controlled facilities amid healthcare boom